192 - Transplant ID 101 for the General ID Practitioner

Saturday, October 19, 2024

8:00 AM – 9:00 AM US PT

Location: 403 A

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1 hours of MOC Credit
CNE Credits: Maximum of 1 hours of ANCC Credit
ACPE Credits: ACPE 1 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Senu Apewokin, MD

Assoc Prof
University of Cincinnati
Mason, OH, United States
Ruth Adekunle, MD, MSCR (she/her/hers)

Assistant Professor of Medicine
Infectious Diseases
Medical University of South Carolina
Charleston, SC, United States

Faculty(s)

Joshua Hill, MD

Associate Professor
Fred Hutchinson Cancer Center; University of Washington
Seattle, WA, United States
Cameron Wolfe, MBBS, MPH, FAST, FIDSA

Professor of Medicine
Department of Medicine
Duke University
Durham, NC, United States

Disclosure(s):

Senu Apewokin, MD: Nestle/Seres: Stocks/Bonds (Public Company) (Terminated, June 30, 2023); Speakers Bureau for Nestle Health Science: Honoraria (Ongoing)

Ruth O. Adekunle, MD, MSCR: No financial relationships to disclose

Joshua A. Hill, MD: AlloVir: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Century Therapeutics, Inc: Advisor/Consultant (Terminated, May 31, 2023); CSL Behring: Advisor/Consultant (Ongoing); Deverra: Grant/Research Support (Ongoing); GeoVax: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Gilead Australia: Advisor/Consultant (Terminated, February 28, 2024); Karius: Advisor/Consultant (Ongoing); Merck: Grant/Research Support (Ongoing); Moderna: Board Member (Terminated, January 6, 2024); Modulus: Advisor/Consultant (Ongoing); Oxford Immunotec: Grant/Research Support (Ongoing); Senti BioSciences, Inc: Advisor/Consultant (Ongoing); Takeda: Advisor/Consultant (Terminated, December 31, 2022); Up-to-Date: Advisor/Consultant (Terminated, June 7, 2023)

Cameron R. Wolfe, MBBS, MPH, FAST, FIDSA: Atea Pharmaceuticals, Inc.: Advisor/Consultant (Ongoing); Invivyd, Inc.: Advisor/Consultant (Terminated, April 1, 2024); Janssen Infectious Disease: Advisor/Consultant (Ongoing)

Learning Objectives:

At the conclusion of this session, participants will be able to:

Identify the net state of immunosuppression and infection risk over time in organ and cellular therapy (e.g. HCT , CAR-T) recipients;
master critical management concepts in caring for organ and cellular therapy (e.g. HCT , CAR-T) recipients.

Presentations:

8:00 AM – 8:30 AM US PT

Review of infection prevention strategies for HCT and CAR-T cell therapy recipients
Speaker: Joshua A. Hill, MD – Fred Hutchinson Cancer Center; University of Washington
8:30 AM – 9:00 AM US PT

Review of management strategies for SOT recipients
Speaker: Cameron R. Wolfe, MBBS, MPH, FAST, FIDSA – Duke University